Drug shows promise in boosting 'good' cholesterol

A clinical study of the new drug anacetrapib shows a dramatic increase in HDL cholesterol levels, seen as a key to lowering heart disease risk, without the side effects seen in a previous drug. A medication under development dramatically raises good cholesterol, reduces bad cholesterol and, so far, appears safe, researchers reported Wednesday.

Read the whole article on LA Times - Science

More from LA Times - Science